Journals / Van Tıp Dergisi / 2013 / Cilt: 20 - Sayı: 4

Candida esophagitis in an immunocompetent pregnant woman: Case report

İmmünsistemi normal olan bir gebede candida özefajit; olgu sunumu

Pages
230–232
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In conclusion, pregnant patients who don’t respond to symptomatic treatment for refractory nausea, vomiting and weight loss should be evaluated by endoscopy for candida esophagitis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Nausea and vomiting in the first half of pregnancy is very common and often need supportive treatment.
📊
Key Findings & Data:In this case report we aimed to present candida esophagitis in an immunocompetent pregnant woman.
💡
Conclusion & Impact:In conclusion, pregnant patients who don’t respond to symptomatic treatment for refractory nausea, vomiting and weight loss should be evaluated by endoscopy for candida esophagitis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Nausea and vomiting in the first half of pregnancy is very common and often need supportive treatment. In this case report we aimed to present candida esophagitis in an immunocompetent pregnant woman. Because of refractory nausea and vomiting not responding to supportive treatment, upper gastrointestinal endoscopy was performed and was diagnosed with candida esophagitis. Investigations of underlying immunodeficiency was performed. Human immundefiency virus (HIV) antibody were negative. T-cell subset were within normal range. Oral nystatin treatment was started. The esophagitis resolved completely when reassessed on fifth day of nystatin treatment. At the end of the treatment her symptoms disappeared. In conclusion, pregnant patients who don’t respond to symptomatic treatment for refractory nausea, vomiting and weight loss should be evaluated by endoscopy for candida esophagitis. It can be treated easily with nystatin.

Özet

Bulantı ve kusma gebeliğin ilk yarısında çok yaygındır ve genellikle destek tedavisi gerekir. Bu olgu sunumunda immünyetmezliği olmayan gebe hastada kandida özafajitinin sunulması amaçlanmıştır. Destek tedavisine cevap vermeyen inatcı bulantı ve kusması nedeniyle hastaya üst gastrointestinal endoskopi yapıldı ve candida özefajit tanısı konuldu. Altta yatan immün yetmezlik olup olmadığı araştırıldı. Human immundefiency virüs (HIV) antikoru negatif bulundu. T cell hücre grubu normal sınırlarda idi. Oral nystatin tedavisi başlandı. Nystatin tedavisinin beşinci gününde özefajit gastrointestinal endoskopi ile tekrar değerlendirildiğinde özefajit tamamıyla düzeldi. Tedavinin sonunda hastanın semptomları kayboldu. Sonuç olarak inatçı bulantı, kusma ve kilo kaybı olan ve semptomatik tedaviye cevap vermeyen gebeler endoskopik olarak, kandida özefajit için değerlendirilmelidirler.

🔖

Cite This Article

YÜKSEL, M. A., TURHAN, A., TEMEL, İ., HAVARE, N., BORAN, A. B. (2013). Candida esophagitis in an immunocompetent pregnant woman: Case report. Van Tıp Dergisi, Cilt: 20 - Sayı: 4, 230–232. https://ajindex.com/articles/334853

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. McDonald GB, Sharma P, Hackman RC, Meyers JD, Thomas ED. Esophageal infections in immunosuppressed patients after marrow transplantation. Gastroenterology 1985
  2. 88(5 Pt 1):1111-1117. 2.Ramanathan J, Rammouni M, Baran J Jr, Khatib R. Herpes simplex virus esophagitis in the immunocompetent host: an overview. Am J Gastroenterol 2000
  3. 95(9):2171-2176. 3.Simon MR, Houser WL, Smith KA, Long PM. Esophageal candidiasis as a complication of inhaled corticosteroids. Ann Allergy Asthma Immunol 1997
  4. 79(4):333-338. 4.Chocarro Martínez A, Galindo Tobal F, Ruiz- Irastorza G, González López A, Alvarez Navia F, Ochoa Sangrador C, et al. Risk factors for esophageal candidiasis. Eur J Clin Microbiol Infect Dis 2000
  5. 19(2):96-100. 5.Wilcox CM, Karowe MW. Esophageal infections: etiology, diagnosis, and management. Gastroenterologist 1994
  6. 2(3):188-206. 6.Yee J, Wall SD. Infectious esophagitis. Radiol Clin North Am 1994
  7. 32(6):1135-1145. 7.Baehr PH,McDonald GB.Esophageal infections: risk factors, presentation, diagnosis, and treatment. Gastroenterology 1994
  8. 106(2): 509-532. 8.Walsh TJ, Pizzo PA. Nosocomial fungal infections: a classification for hospital-acquired fungal infections and mycoses arising from endogenous flora or reactivation. Annu Rev Microbiol 1988
  9. Sangeorzan JA, Bradley SF, He X, Zarins LT, Ridenour GL, Tiballi RN, et al. Epidemiology of oral candidiasis in HIV-infected patients: colonization,infection, treatment, and emergence of fluconazole resistance. Am J Med 1994
  10. 97(4):339-346. 10.Kogan J. Herpes simplex and Candida esophagitis. IMJ Ill Med J 1986
  11. 169(6):366- 368. 11.Samonis G, Skordilis P, Maraki S, Datseris G, Toloudis P, Chatzinikolaou I, et al. Oropharyngeal candidiasis as a marker for esophageal candidiasis in patients with cancer. Clin Infect Dis 1998
  12. 27(2):283-286. 12.Bonacini M, Young T, Laine L. The causes of esophageal symptoms in human immunodeficiency virus infection. A prospective study of 110 patients. Arch Intern Med 1991
  13. 151(8):1567-1572. 13.Vermeersch B, Rysselaere M, Dekeyser K, Rasquin K, De Vos M, Elewaut A, et al. Fungal colonization of the esophagus. Am J Gastroenterol 1989
  14. 84(9):1079-1083. 14.Greenspoon JS, Kivnick S. Candida esophagitis in an immunocompetent pregnant woman. Infect Dis Obstet Gynecol 1993
  15. 1(3):149-152. 15.Vazquez JA, Sobel JD. Mucosal candidiasis. Infect Dis Clin North Am. 2002
  16. 16(4):793-820. 16.Ostrosky-Zeichner L, Rex JH, Bennett J, Kullberg BJ. Deeply invasive candidiasis. Infect Dis Clin N